Heyholder
‹ Activism Filings

HIGH TECH PHARM CO.,LTD. Q3 operating profit KRW 1.1 billion, down 71.8% from a year earlier

HIGH TECH PHARM CO.,LTD.· Periodic Report

AI summary · Not investment advice

Hi-Tech Pharm sold KRW 18.7 billion worth in Q3 and earned KRW 1.1 billion from its main business, down 71.8% from a year earlier.

Operating profit · 3 months

KRW 1.1 billion

Key facts

Revenue (3 months)
KRW 18.7 billion
Net income (3 months)
KRW -774.0 million
Period
Q3 (cumulative 2026.01.01 ~ 2026.09.30)
Revenue (prior-year 3 months)
KRW 17.9 billion
Revenue (year to date)
KRW 56.2 billion
Operating profit (prior-year 3 months)
KRW 3.9 billion
Operating profit (year to date)
KRW 6.3 billion
Net income (prior-year 3 months)
KRW 3.8 billion
Net income (year to date)
KRW 4.2 billion

Commentary

AI commentary · Not investment advice

What happened

Hitech Pharm filed its quarterly report for the 3rd quarter of 2026, on a standalone basis. Sales for the 3 months were KRW 18.68 billion, up 4.6% from KRW 17.87 billion a year earlier.

In the company's terms

Operating profit (profit from the core business) for the 3 months was KRW 1.10 billion. That is down 71.8% from KRW 3.91 billion a year earlier. Net income (the final profit after taxes and other costs) for the 3 months was a loss of KRW 0.77 billion. A year earlier it was a profit of KRW 3.79 billion, so it turned into a loss.

What changes for shareholders

For the year to date (Jan 1 to Sep 30), sales were KRW 56.19 billion. Operating profit was KRW 6.30 billion and net income was KRW 4.20 billion.

Comments

No comments yet

Comments from shareholders will appear here.